Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
about
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of the Anti-Angiogenesis ...... h Stage III Malignant Melanoma
@en
type
label
Study of the Anti-Angiogenesis ...... h Stage III Malignant Melanoma
@en
prefLabel
Study of the Anti-Angiogenesis ...... h Stage III Malignant Melanoma
@en
P1050
P1476
Phase 2 Study of the Anti-Angi ...... h Stage III Malignant Melanoma
@en
P3098
NCT01321437
P4844
P580
2011-12-01T00:00:00Z
P582
2019-12-01T00:00:00Z